- Tytuł:
- Phase 2 study of AV-GBM-1 (a tumor-initiating cell targeted dendritic cell vaccine) in newly diagnosed Glioblastoma patients: safety and efficacy assessment
- Autorzy:
- Źródło:
- Journal of Experimental & Clinical Cancer Research. 41(1)
Czasopismo naukowe